Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for cystic acne treatment is witnessing first-rate traits driven by using improvements in skincare, developing attention to dermatological situations and a demand for powerful healing options. These tendencies are reshaping the panorama of cystic acne management to cope with the challenges confronted by way of people handling extreme styles of pimples. A key trend inside the cystic acne market entails the development and utilization of topical and oral remedy modalities. Dermatologists regularly prescribe topical retinoids, benzoyl peroxide, and antibiotics to control inflammation. Additionally, oral medicinal drugs like oral antibiotics and hormonal treatment options are employed to address systemic factors contributing to cystic acne. The market is experiencing a surge in superior topical formulations designed to decorate the efficacy and tolerability of pimple treatments.
The adoption of telemedicine is influencing how individuals are seeking dermatological consultations for cystic acne. Virtual appointments permit sufferers to hook up with dermatologists remotely, facilitating timely recommendations and remedy adjustments. Telemedicine is mainly useful for people with confined access to in-man or woman dermatological care. Skincare innovation is playing a pivotal role in cystic acne control. The market is witnessing the creation of revolutionary skin care merchandise that focuses on non-comedogenic formulations, gentle exfoliation, and hydration. These products are designed to supplement medical remedies and aid standard skin fitness. A noticeable trend is the emphasis on training the affected person and self-care in managing cystic acne. Dermatologists and skincare experts are actively educating people about proper skin care workouts, lifestyle factors, and capacity triggers. This trend empowers sufferers to play an energetic role in their acne management.
Holistic strategies for cystic acne management are gaining traction. Integrative strategies that don't forget nutritional conduct, strain control, and ordinary well-being are being explored along with conventional medical interventions. This trend displays a comprehensive view of pimples as a multifactorial condition. Over-the-counter (OTC) solutions for cystic acne are becoming more varied and extensively to be had. Individuals can select from various OTC merchandise containing substances like salicylic acid, niacinamide, or sulfur. This trend contributes to accelerated accessibility and alternatives for those searching for self-care solutions. Ongoing studies are targeted at exploring novel healing procedures for cystic acne. From investigating the role of the pores and skin microbiome to exploring anti-inflammatory dealers, researchers are actively looking for new ways to identify the underlying factors contributing to cystic acne.
Cystic Acne Market Highlights:
Cystic Acne Market Overview
Cystic Acne Market Size was valued at USD 7.36 Billion in 2023. The Cystic Acne industry is projected to grow from USD 7.97 Billion in 2024 to USD 14.98 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.01% during the forecast period (2024 - 2032).
Cystic acne is the most serious type of acne, it is the type of skin condition wherein the pores of the skin get blocked, which leads to infection or inflammation of the affected area of the skin. Sometimes bacteria get trapped inside the pore and swell the infected skin area. It happens when the infection went deep into the skin and spread throughout the body. Although bacterium (P. acne bacteria) causes the cystic acne, which also causes papules, pustules, and such others, Cystic acne lesions are one of the most difficult acne to treat. These lesions are more painful and have a risk of scarring the skin and causing a permanent damage as compared to mild or moderate acne.
According to the American Academy of Dermatology Association, around 50 million Americans get affected annually with acne, and it is the most common skin condition in the Americas. Additionally, approximately 85% of people between the ages of 12 and 24 experience at least minor acne.
Rising prevalence of this conditions both in developed and developing countries is driving the cystic acne market growth. The skin care industry and research laboratories are involved in research and development to provide the better treatment. According to Leon H. Kircik, M.D., clinical associate professor of dermatology at Indiana University School of Medicine, recent research on severe and moderate acne patients with inflammatory acne helps to confirm the strength and efficacy of fixed-dose combination gel adapalene/benzoyl peroxide 0.3%/2.5%.
The factors that cause cystic acne are too much oil production in the glands of the skin and growth of the bacteria called Propionibacterium acnes. Moreover, advancing technology in healthcare is adding fuel to the growth of the market. However, effective treatments are not available in the market, which may hamper the market growth during the forecast period.
Intended Audience
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Figure: Global Cystic acne Market, By Region Market Share, 2016 (%) 
Sources: Annual reports, Press release, White paper, Company presentation
Cystic Acne Market Segment Insights
The global cystic acne market is segmented on the basis of causes, long-term effects, treatment type, and end user.
On the basis of the causes, it is segmented into hormonal imbalances, occlusive skin products, drugs/chemical side effects, and others.
On the basis of the long-term effects, it is segmented into ice pick scars, larger pits on the skin, shallow depressions, hypertrophic scarring, and others.
On the basis of the treatment type, it is segmented into topical medications, drainage & extraction procedure, laser therapy, microdermabrasion, and others.
On the basis of the end user, it is segmented into hospitals, clinics, research laboratories, and others.
Cystic Acne Market Regional Analysis
The Americas dominate the global cystic acne market owing to well-developed technology and increasing population with acne. Key players are focusing on capturing maximum share of the emerging markets such as India and China. According to American Academy of Dermatology Association, in 2016 the costs associated with the treatment of acne exceed USD 3 billion.
Europe holds the second position in the global cystic acne market owing to the government support for research & development and availability of funds for research. This is expected to drive the European cystic acne market over the forecasted period.
The Asia Pacific is the fastest growing cystic acne market owing to the presence of rapidly growing patient population, and high healthcare expenditure. The government of this region focuses more on providing better treatment to the citizen of their countries for improving their quality of life.
On the other hand, in the Middle East and Africa, cystic acne has become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.
Cystic Acne Market- Key Players
Some of the key players in this cystic acne market are
- GlaxoSmithKline plc (U.K)
- Pfizer Inc. (U.S.)
- Abbott Laboratories (U.S.)
- Hexal AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Alma Lasers Inc. (Israel)
- Bristol-Myers Squibb Company (U.S.)
- GE Healthcare (U.K)
- National Biological Corp. (U.S.)
- Herbert Waldmann GmbH & Co. KG (Germany)
- Sylvan Company (U.S.)
- DUSA Pharmaceuticals Inc. (U.S.)
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
